. 2024 Oct 9;15:1465363. doi: 10.3389/fphar.2024.1465363
Copyright © 2024 Mateen, Khan, Khan, Ahmad, Khan and Salam.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
FIGURE 5.
Cell viability of HepG2 cell lines by the reference drug and sorafenib nanoformulation.